These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37440312)

  • 1. Impact of a Pediatric Emergency Medicine Pharmacist, Institutional Guideline, and Electronic Order Set on Empiric Antimicrobial Use for Febrile Neutropenia.
    Aluisio YM; Sanchez AC; Norris KR; Waller J; Campbell CT
    Pediatr Emerg Care; 2024 Feb; 40(2):151-155. PubMed ID: 37440312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of emergency medicine clinical pharmacist practitioner-driven sepsis antibiotic interventions.
    Hammond A; Porter R; Lynch KE; Cason TH; Passaretti P
    Am J Emerg Med; 2024 Feb; 76():24-28. PubMed ID: 37979228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial Therapy for Pneumonia in the Emergency Department: The Impact of Clinical Pharmacists on Appropriateness.
    Faine BA; Mohr N; Dietrich J; Meadow L; Harland KK; Chrischilles E
    West J Emerg Med; 2017 Aug; 18(5):856-863. PubMed ID: 28874937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing Time to Antibiotic Administration for Febrile Neutropenia in the Emergency Department.
    Keng MK; Thallner EA; Elson P; Ajon C; Sekeres J; Wenzell CM; Seastone DJ; Gallagher EM; Weber CM; Earl MA; Mukherjee S; Pohlman B; Cober E; Foster VB; Yuhas J; Kalaycio ME; Bolwell BJ; Sekeres MA
    J Oncol Pract; 2015 Nov; 11(6):450-5. PubMed ID: 26220930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guideline adherence for the management of emergency department patients with febrile neutropenia and no infection source: Is there room for improvement?
    Jansma B; Vakkalanka P; Talan DA; Negaard B; Faine BA
    J Oncol Pharm Pract; 2020 Sep; 26(6):1382-1389. PubMed ID: 31955667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency department management of chemotherapy related febrile neutropenia: An opportunity to improve care.
    Pettit N; Boadu D; Bischof JJ
    Am J Emerg Med; 2021 Dec; 50():5-9. PubMed ID: 34265732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Outcomes With Febrile Neutropenia Based on Time to Antibiotics in the Emergency Department.
    Dessie AS; Lanning M; Nichols T; Delgado EM; Hart LS; Agrawal AK
    Pediatr Emerg Care; 2022 Jan; 38(1):e259-e263. PubMed ID: 32941363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
    Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of an emergency medicine pharmacist on empiric antibiotic prescribing for pneumonia and intra-abdominal infections.
    Kulwicki BD; Brandt KL; Wolf LM; Weise AJ; Dumkow LE
    Am J Emerg Med; 2019 May; 37(5):839-844. PubMed ID: 30097272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making Improvements in the ED: Does ED Busyness Affect Time to Antibiotics in Febrile Pediatric Oncology Patients Presenting to the Emergency Department?
    Benner CA; Mora E; Mueller E; Seagull FJ; Walkovich K; Johnson K; Halverson S; Rothman E; Hucks G; Younger JG; Nypaver MM
    Pediatr Emerg Care; 2018 May; 34(5):310-316. PubMed ID: 27749799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to Antibiotic for Pediatric Oncology Patients With Febrile Neutropenia at Regional Emergency Departments.
    Wadhwa A; Oakley J; Richman J; Bhatia S; Kutny MA
    Pediatr Emerg Care; 2022 Jan; 38(1):e94-e99. PubMed ID: 32569251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines.
    Naeem D; Alshamrani MA; Aseeri MA; Khan MA
    Pharmacy (Basel); 2018 Aug; 6(3):. PubMed ID: 30103459
    [No Abstract]   [Full Text] [Related]  

  • 13. Febrile neutropenia in EDs: the role of an electronic clinical practice guideline.
    Lim C; Bawden J; Wing A; Villa-Roel C; Meurer DP; Bullard MJ; Rowe BH
    Am J Emerg Med; 2012 Jan; 30(1):5-11, 11.e1-5. PubMed ID: 21030183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia.
    Vicente M; Al-Nahedh M; Parsad S; Knoebel RW; Pisano J; Pettit NN
    J Oncol Pharm Pract; 2017 Dec; 23(8):575-581. PubMed ID: 27609336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of the Implementation of a Pharmacist-Driven Protocol of Second Dose Cefepime for Adult Patients With Sepsis in the Emergency Department at a Tertiary Care Academic Medical Center.
    Miele S; Gohel A; Cham S; Brady J
    J Pharm Pract; 2024 Oct; 37(5):1061-1065. PubMed ID: 37941339
    [No Abstract]   [Full Text] [Related]  

  • 16. Appropriateness of antibiotic selection for pneumonia in the emergency department: pre- and post-order set changes.
    Wang HY; Treu CN; Cocca M; Felton D; Gatton B
    Int J Pharm Pract; 2021 Oct; 29(5):493-498. PubMed ID: 34302480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist-driven antimicrobial optimization in the emergency department.
    Davis LC; Covey RB; Weston JS; Hu BB; Laine GA
    Am J Health Syst Pharm; 2016 Mar; 73(5 Suppl 1):S49-56. PubMed ID: 26896526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Time to Antibiotics for Pediatric Oncology Patients With Suspected Infections: An Emergency Department-Based Quality Improvement Intervention.
    Yoshida H; Leger KJ; Xu M; Migita RT; Rutledge JC; Pollard JA; Kroon L; Mazor SS; Moon A; Rutman LE
    Pediatr Emerg Care; 2018 Jan; 34(1):47-52. PubMed ID: 29293201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia.
    Daniels LM; Durani U; Barreto JN; O'Horo JC; Siddiqui MA; Park JG; Tosh PK
    Support Care Cancer; 2019 Nov; 27(11):4171-4177. PubMed ID: 30805726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limiting Vancomycin Exposure in Pediatric Oncology Patients With Febrile Neutropenia May Be Associated With Decreased Vancomycin-Resistant Enterococcus Incidence.
    Karandikar MV; Milliren CE; Zaboulian R; Peiris P; Sharma T; Place AE; Sandora TJ
    J Pediatric Infect Dis Soc; 2020 Sep; 9(4):428-436. PubMed ID: 31603472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.